Skip to main content
. Author manuscript; available in PMC: 2021 Jul 10.
Published in final edited form as: Sci Transl Med. 2021 Mar 10;13(584):eabb3945. doi: 10.1126/scitranslmed.abb3945

Fig. 2. Average plasma concentration-time profiles of siRNA and Au following intravenous infusion in recurrent GBM patients.

Fig. 2.

(A) Key pharmacokinetic parameters of siRNA and Au in patient plasma. Standard deviations are indicated in brackets. (B) Plot of average plasma concentration time profiles of siRNA and Au following an IV Infusion with NU-0129; lower panel shows graph truncated at the 2 hrs time point post infusion. Data points are shown ± standard deviations. Blood was drawn at 0, 1, 3, 5, 10 min, 0.5, 1, 4, 8 and 24 hrs post NU-0129 infusion.